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ABSTRACT : To investigate the effect of OK-432 and 1-arginine HC1 on the artificial 
metastases in lung, mice were injected mouse colon carcinoma, colon 26 cells(1×10 6). 
   Pulmonary nodules produced by the i. v. injection of 1×10 6 colon tumor 26 cells into 
a caudal vein were evaluated after 3 weeks. 
   OK-432, 1KE/mouse, was administered by the i. v. injection three times on day 0, 2, 
4 after the tumor injection. 
   L-arginine HC1, 50mg/mouse, was given by the i. p. injection 6-7 times on day 0, 1, 
2,3,4,5,6. 
   IV administration of OK-432 led to a significant suppression of lung metastases 
formation in comparison to salin-injected animals. Furthermore, OK-432 and i. p. 
administration of 1-arginine HC1 let to a considerable, synergisticaly retardation of tumor 
metastasis. 
   The suppressive effect of OK-432 and 1-arginine HC1 on the artificial lung metastases 
may be due to its activation of the immunologic system. 
   And this work suggest that OK-432 and 1-arginine HC1 enhanced the phagocytic 
activity of macrophages in vivo.
       INTRODUCTION 
 OK-432, a streptococcal preparation, has been 
developed by Okamoto in Japan. 
 This agent has been used in cancer patients 
and beneficial clinical outcome has been noted, 
OK-432 is a potent immune modulating agent 
in both animal models and cancer patients and 
possesses therapeutic efficacy. 
 Introvenous hyperalimentation was first re-
ported by Dudrick and is now most easily used 
in every hospitals for nutritional support. 
 Harper" first suggested the therapeutic value 
of amino acid imbalance in treatment of ma-
lignant disease. 
 Recentry, it has been reported that the addi-
tion of excess 1-arginine HCl resulted in protec-
tion against the growth of a transplantable 
tumor. 
 In this study, we examined the effect of 
OK-432 and 1-arginine HC1 on the artificial lung 
metastasis in Balb/c mice. 
 And conbined treatment by OK-432 and 
1-arginine HC1 was significantly effective in 
artificial lung metastases. 
 Then, we examined the therapeutic mechan-
ism of OK-432 and 1-arginine HC1. 
 It is suggested that the protection of early 
artificial metastases in mice by OK-432 and 
1-arginine HCl may be due to the phagocytotic 
macrophages eliciated by them indirectly. 
 Harper" first reported the antitumor effect of 
arginine on daietary imbalance. In fact, it has
been known that arginine supplementation can 
alleviate the negative effect of recovery from 
trauma. On the other hand, arginine deficiency 
impaires wound healing process in rats with 
trauma. 
 A large amounts of administration of arginine 
focus our attention on enhancement of anti-
tumor effect. In addition, other reports clarify 
that antitumor efects are facilitated in conjunc-
tion with arginine and biological response 
modifies (BRM). The purpose of this study is 
to certify as to whether a combination with 
arginine and OK-432, streptococcal lyophilized 
preparation as a kind of BRM, potentially acts 
as antitumor effect. 
 In this study, antitumor effects of arginine and 
OK-432 were tested in mice lung metastases.
   MATERIALS AND METHOD 
(1) Experimental animals: 
 Colon tumor 26 was transplanted in Balb/c 
mice, female, aged 8-10 weeks. 
 BL-6 melanoma was transplanted in C57BL/ 
6 mice, female, aged 8-10 weeks. The animals 
were obtained from Shizuoka Animal Facility 
Center, Shizuoka, Japan and acclimatized for 1 
week to our laboratory conditions before ex-
periments. 
 All animals were kept in a room at a constant 
temperature of 22±1°C. 
(2) Experimental tumors : 
 Colon Tumor 262' is induced with DMH 
(Dimethyl hydragine) and it is an undiffer-
entiated Grade 4 carcinoma. The lung were the 
major site of metastases. Colon Tumor 26 was 
grown in monolayer culture in RPMI-1640 me-
dium supplemented with 10% heated-inacti-
vated fetal calf serum in a humidified 5% CO2 
atmosphere at 37CC 
 B16-BL6 mouse melanoma cells were main-
tained in vitro at 37°C in a humidified 5% CO2 
plus 95% air atmosphere using RPMI-1640 me-
dium supplemented with 10% heated-inacti-
vated fetal calf serum. 
 The cells were maintained in vitro as a 
monolayer culture using plastic tissue culture 
flasks and subcultured weekly using 0.25% 
trypsin-0.02% EDTA. 
(3) Accurate Indication of Experimental Pulmo-
nary Metastasis' 
 Pulmonary nodules produced by the iv 
injection of 1 x 106 colon turner 26 cells into a 
caudal vein were evaluated, and mice were 
sacrificed after 3 weeks. 
 The sacrificed animal was pinned to a 
dissecting board in the supine position, and 
trachea and chest cavity were exposed through 
a mid line chest incision. The trachea was 
isolated and a #22 blunt needie was inserted 
into the transected end of the trachea. 2m1 of 
India ink (15ml India ink, 85ml of distilled water, 
two drops of ammonia water) was injected with 
gentle spring pressure. 
 Then, the lung were dissected, en bloc, from 
the thoracic cage and placed in a beaker of tap 
water for at least 5 minutes. The organ was 
then placed in Feketes solution (100ml of 70% 
alcohol, 10ml of formaldehyde, and 5m1 of glacial 
acetic acid) for 24 hours. Then, metastatic 
tumor foci of seperating the lobes of the lung 
wer counted easily. 
(4) OK-432 and 1-arginine HCI : 
 OK-432 was administrated at 1KE per one 
mouse, on day 0, 2, 4 after i. v. injection of colon 
26. OK-432 was diluted with salt solution to 
1KE/0.lml. 
 OK-432 was supplied by Chugai Co., Japan 
in vials. This phermaceutical preparation is 
standardized by a variety of tests and a unit 
of "KE" (= Klinische Einheit) is used to express 
the strengh of the preparation. 
 Daily injections of 1-arginine HC1 into mice 
bearing colon 26 tumors was done for 6 days 
starting after inoculation of colon 26 tumors. 
Mice received intraperitoneal (ip) injection of a 
dose of 50mg 1-arginine HCl for 6 days running. 
(5) Anti asialo GM14' 5', Carrageenan6), Arginase: 
 (i) Purified asialo GM1 from bovine brain 
tissue was repeatedly immunized with mouse 
methylated bovine serum albumin and with 
complete Freund's adjuvant. 
 This product react with mouse natural killer 
cells, a part of mouse monocytes and immature 
mouse fetal thymocytes. 
 20pl anti asialo GM1 was iv injected three 
times on day of 0, 4, 8. 
 (ii) Carrageenan was dissolved in saline by 
being heated to 100CC for 10 minutes in a water 
bath, mice were given 1mg iv one shot in 0.lml
saline, immediately after inoculation of colon 26. 
(iii) Arginase 50unites/mouse was injected ip for 
5 times, starting immediately after inoculation 
of colon 26. 
 One unit will convert 1.0,umole of 1-arginine 
to ornithine and urea per minute at pH 9.5 at 
37°C. 
(6) Statistical analyses : 
 Statistical analyses of changes in metastasis 
formation were performed by Student's t-test.
          RESULTS 
(1) Effect of 1-arginine HCL and/or OK-432 on 
induced lung metastasis (colon 26 cell line) (Fig. 
1 and Table 1). 
 When colon 26 cells were transfered in Balb/c 
mice, three weeks later, lung metastases de-
veloped with an average of 194±39 in number. 
 The addition of OK-432 iv showed an average 
of 71±36 (p<0.01) and 31±17 (p<0.01) in
conjunction with Arg. 
 When Arg alone was used, these were 138± 
35 without significant difference from the 
control. The use in combination with Arg and 
OK-432 enabled lung metastasis to significantly 
reduce (p<0.05). And also this study was un-
dertaken to define immunologic mechanisms of 
inhibition of the tumor growth. 
(2) Effect of combined therapy is dependent on 
the time period of administration (Table 2) 
 When Arg and OK-432 were given prior to 
implantation of tumor cells to mice, the number 
of lung metastasis showed an average of 126± 
70. On day 3 after implantation of tumor cells 
to mice, it was 105±58 and 31±17 on day 0 
respectively. 
 The results indicated that combination ther-
apy with Arg and OK-432 was of great benefit 
to reduce lung metastasis regardless of prior to 
and/or after implantation of tumor cells. In 
addition, the maximum effect of combined
Fig. 1. Metastatic nodules in lung of Balb/c mice. 
      A ; control 
      B ; OK-432 
      C ; Arg+OK-432
therapy on inhibition of tumor cell growth was 
defined at the same time as implantation of 
tumor cells. 
(3) The concentration of Arg in the plasma, the 
lung and the liver (Fig. 2) 
 When a dosis of 50mg of 1-Arg HCL was given 
intraperitoneally, there was no difference in the 
concentrations of the liver. On the other hand, 
the concentrations of Arg increased double from 
30 nmol/ml to 60 nmol in the blood and from 
140 nMol/ml to 180 nMol/ml in the liver. 
(4) Effect of arginine on lung metastasis 
 When arginase, an enzym of degradation of 
arginine, in addition to OK-432 was injected 
intraperitoneally to make clear of the role of 
arginine on the arginine deficient condition. 
 Table 3 showed that the number of lung 
metastasis in Balb/c mice was not significant 
difference among the control, arginase and 
arginase+OK-432 groups. 
(5) Effect of a decrease in NK activity by
Table 1. Effect of OK-432 and/or 1-Arginine HCl 
        on artificial metastases of colon 26 cells
        in Balb/c mice 
    Treat. No. of Lung meta. t-test 
             mice Mean±SD 
Cont. 15 194±39 
- OK-432 10 71+36 P<0.01 P<0
.05 OK
-432+Arg . 10 31+17 P<0.01 
Arg. 10 138±35 N. S.
Table 2. Effect of OK-432 and 1-Arginine HC1 on 
        artificial metastases of colon 26 cells in
        Balb/c mice (Depend on injection period)
Treated period No. of mice Lung meta. t-test                       M
ean±SD 
No treatment 15 194±39 
- Before 5 126±70 P<0.05 
After 6 105±58 P<0.01 
Synchronous 10 31±17 P<0.01
Table 3. Effect of Arginase on artificial metastases 
        of colon 26 cells in Balb/c mice
   Treat. No. of Lung meta. t-test                   mice Mean±SD 
Control 15 194±39 -
Arginase 5 232±34 N. S. 
Arginase+OK-432 5 225±25 N. S.
anti-asialo GM/Ab on lung metastasis in mice 
(Table 4) 
 The number of lung metastasis showed 234+-
38 when administering OK-432, indicating not 
significant difference in comparison with the 
control. 
 In contrast, while the combination therapy 
with Arg and OK-432 was instillated, the number 
of lung metastasis was reduced to 82±77 with 
a significant difference. 
(6) Effect of carrageenan on lung metastasis 
(Table 5 ) 
 An average of 159±73 in pulmonary metasta-
sis was numbered when administering OK-432 
in addition to corrageenan in contrast to 194± 
77 in the control. On the other hand, it was 
174±94 in combination with Arg and OK-432. 
 There was no definitive difference in the 
number of lung metastasis between Arg and 
Arg+OK-432 in addition to carrageenan. 
(7) Effect of OK-432 and Arg on lung metastasis
Table 4. Effect of Anti-asialoGMl Ab on artificial 
        metastases of colon 26 cells in Balb/c mice 
     Treat. No. of Lung meta. t-test
               mice Mean +SD 
Control 5 256+14 -
OK-432 5 234±38 N. S. 
OK-432+Arg. 6 82±77 <0.01
Table 5. Effect of Carrageenan on artificial meta-
        stases of colon 26 cells in Balb/c mice
   Treat. No. of Lung meta. t-test 
               mice Mean±SD 
Cont. 5 194±77 -
OK-432 5 159±73 N. S. 
OK-432+Arg. 6 174±94 N. S.
Table 6. Effect of OK-432 and 1-Arginine HCI on 
        artificial metastases of B16-BL6 cells in
       C57BL/6 mice 
  Treat. No. of Lung meta. t-test                  mice Mean-
-+-SD 
Cont. 5 42±16 
- OK-432 5 19±10 P<0.05 P<0
.05 OK
-432+Arg . 5 2±4 P<0.01
Fig. 3. Metastatic nodules in lung of C57BL/6 mice. 
     A ; control B ; OK-432 C ; Arg+OK-432
of B16-B16 cells in C57 BL/6 mice (Table. 6 and 
Fig. 3) 
 Table 6 showed significant inhibition of lung 
metastasis of B16-BL6 cells in C57BL/6 mice 
when OK-432 or Ar+OK-432 were used. The 
numbers of lung metastases were diminished 
from 42±16 in the control to 19±10 in OK-432 
group and 2±4 in Arg+OK-432 group with 
statistically significant difference (p<0.05 and 
p<0.01 respectively). 
 Diminished metastasic nodules in the lung 
were shown in Fig. 3 in cases of the control, 
OK-432 and OK-432+Arg groups.
         DISCUSSION 
 Harped' first reported the antitumor effects 
of nutritional imbalance of amino acids. 
 There are two ways to clinically make use of 
antitumor effect of amino acid imbalance, in-
duced supplement and/or deficiency of amino 
acids. 
 However, the treatments of amino acids 
imbalance were mainly used for a deficiency 
of essential amino acids such as methionin,
tryptophan and phenylalanine. Nutritional 
imbalance of amino acids provids a great effect 
on proliferation of tumor cells and promotion 
of metastasis and recurrence. In particular, a 
deficiency of essential amino acids influences 
on the metabolism of cancer cells as well as 
normal cells. 
 It is necessary to search for the endpoint of 
the minimum ill effect on metabolism in normal 
cells and the maximum ill effect on metabolism 
in cancer cells. Excess administration of Arg 
is most suitable for this purpose. Recently, 
evidence has been accumulated by researh work 
to clarify the antitumor mechanism on excess 
instillation of Arg. Cho-chung7' assumed that 
antitumor effects of Arg might be in association 
with cyclic AMP system. Takeda8' also reported 
the fact of the inhibitory effect on cancer cell 
proliferation and recurrence of breast cancer in 
rats by the addition of Arg supplement. Barbul9' 
clarified that the enlargement of the thymic 
gland and the increase in thymic cells were 
facilitated by the addition of excess adminis-
tration of Arg. He had postulated that the 
antitumor effects of Arg should be in associa-
tion with enhancement of immune surveillance 
system by a stimulation of thymic gland and 
improvement of nutritional state by the addi-
tion of arginine to the hyperalimentation. His 
clinical trial of giving Arg of 30g for seven days 
was conducted in volunteers. As a result, it was 
reported that lymphocytes in the peripherial 
blood was activated without remarkable side 
effect except for slight degree of nausea and 
diarrhea. The results of this study also indi-
cated that exess addition of Arg supplement as 
the imbalance therapy of amino acids was a 
better way to inhibit tumor growth and 
metastasis. 
 Chany10' reported that the anti-tumor effect 
of Arg in conjunction with C parvum or IFN 
resulted in prolongation of the survival time of 
Swiss mice inoculated intraperitoneally with 180 
TG Crocker tumor cells although that of Arg 
alone was not sufficient for elongation of the 
survival in mice. 
 In this study, the antitumor effect of Arg in 
combination with OK-43211', one of BRM, was 
studied as to whether inhibition of tumor growth 
and reduction of pulmonary metastasis were 
experimentally evidenced or not. 
 Many studies in vitro and in vivo clarified that 
OK-432 enhanced the immune response to the 
tumor-bearing hosts. Saito121 suggested that the 
antitumor effect of OK-432 be a direct action 
of INF r induced by OK-432 and/or an indirect 
action of activated macrophages and NK cells 
or differentiated T cels. Much work reported 
that OK-432 also induces non-specific increas-
ed resistance to tumor growht by activated 
macrophages. Toge13' explained that activa-
tion of macrophages by OK-432 is non-T cell 
dependent. The mechanism for antitumor 
action of OK-432 had been ascertained that 
induction of increasing sizes, changes in cell 
shapes and increases resistance to the tumor 
cells were main. 
 When administering Arg in conjunction with 
OK-432 in BAlb/c mice with colon 26 cells, there 
was no significant difference in the number of 
lung metastasis between the control and Arg 
alone. And the number of lung metastasis was 
significantly reduced by administration of Arg 
in conjunction with OK-432. In this study, pul-
monary metastasis was diminished by admin-
istering Arg in conjunction with OK-432. 
 It seemed to be based on activation of the 
immune system. The timing of administration 
of Arg with OK-432 was also studied in relation 
to that of transplantation of tumor cells. The 
timing of administering Arg was divided into 
the three groups, prior to, at the same time and 
following transplantation of tumor cells, respec-
tively. 
 Tanaka14' reported that the antitumor effect 
of OK-432 was prominent when OK-432 was iv 
injected before implantation of AH 7974 tumor 
cells in rats. 
 In this study, the antitumor effect of OK-432 
was manifest when OK-432 was given at the 
same time as the time of implantation. 
 The diversity of the antitumor effect of Arg 
seemed to be in association with differences in 
tumor cells used. 
 When 50mg/mouse of Arg was given ip, the 
concentration of Arg was measured in the blood 
and the lung. 
 The concentration of Arg in the blood reached 
a peak level 2 hours later and that in the lung 
also raised but it returned to the normal 6 hours 
after intraperitoneally giving Arg. Maintenance 
of high concentration of Arg in the blood and 
the lung was limited during a short time. A 
slight increase in Arg concentration in the liver 
was seen. It was a reflection of a presnce of 
a large amount of arginase in the liver. It was 
confirmed that the addition of Arg supplement 
was of great effect to eliminate lung metastasis. 
On the other hand, when arginase was given 
ip, the number of lung metastasis was the same 
as the control and the effect of OK-432 was also 
disappeared. 
 One must take into consideration that in vivo 
presence of Arg may play a role in inhibition 
of tumor growth. It is well known that initial 
steps of progression in metastasis comprises of 
enbeding and extravascular infiltration of tumor 
cells and inhibition of this process may relate 
to activated NK cells, macrophages arid Killer 
T cells which are generated in tumor-bearing 
hosts. In this series, the association of NK cells 
and macrophages with the antitumor effect of 
Arg was studied. The administration of Arg 
in conjunction with OK-432 resulted in a de-
crease in lung metastasis on the condition of
reduced activation of NK cells which was pro-
duced by anti-asialo GM1Ab. 
 Combination administration with Arg and 
OK-432 was beneficial in reducing lung me-
tastasis with statistically significant difference. 
Experimental pulmonary metastasis was as-
sessed when carrageenan was used for reduced 
activation of macrophages in tumor-bearing 
hosts. 
 Combined administration of Arg and OK-432 
was of no use to reduce lung metatasis. The 
result showed that at the initial stage of me-
tastasis, macrophages play a important role in 
inhibition of cancer extension including organ 
metastasis and so it was suggested that the role 
of Arg and OK-432 be based on enhanced 
activity of macrophages. 
 Colon 26 and Balb/c as an experimental 
tumor was selected in this series for an eval-
uation of the antitumor effect of Arg and 
OK-432. In addition, C57BL/6 was also used for 
tumor-bearing hosts. 
 OK-432 alone and in combination with Arg 
was significantly reduced lung metastasis and 
it had become synergistic in conjuction with Arg 
regardless of tumor-bearing hosts and/or the 
kinds of the tumors. 
 Weisburger15' reported that arginine offered 
great effect on inhibition of tumor growth for 
liver tumors which was induced by acetamide 
without any changes in body weight as reproted 
by Yamamoto, Nakanishi, Nakagawa16'. Shimke171 
et al clarified that excess of arginine promote 
metabolism on urea cylce. The mechanism of 
inhibition of tumor growth is that carbonayl-
phosphate moves from pyrimidin synthesis to 
urea cylce from the result of activated urea cycle. 
As a result, synthesis of nucleic acid via de novo 
pathway is inhibited by excess excretion of urea. 
 Davis18' explained that instillation of arginine 
leads to high levels of prolactin, growth hormone 
and insulin in blood. Therefore, enhancement 
of antitumor effect of Arg and OK-432 is 
associated with a stimulation of hormone secre-
tion which helps facilitate cellular immunity of 
the host. Currie19' stated that the addition of 
arginine supplementation resulted in damage to 
and destruction of tumor cells by activated 
macropohages which secrets arginase. 
 In cultured cels, the addition of arginine
enables colon 26 cells to increase and proliferate. 
It is assumed that arginine is not only directly 
influenced on damage to tumor cells but is 
needed for nutrient of tumor growth. Activated 
macrophages is easily in contact with tumor 
cells and cause a destruction of tumor cells with 
help of arginase. In consequence, toumor cells 
has become unable to absorb arginine which is 
needed for metabolism. 
 In conclusion, synergistic effects of Arg and 
OK-432 are explained that OK-432 activate 
macrophage. The addition of Arg much more 
enhanced activation of macrophages and easy 
to access to tumor cells and therefore cause 
damage to tumor cells. Clinical use of amino 
acid imbalance therapy such as the addition of 
Arg in conjunction with OK-432 is of great 
benefit to inhibit lung metastasis.
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